Graves’ disease (GD) is a prototypical organ-specific autoimmune thyroid disorder characterized by hyperthyroidism mediated by thyroid-stimulating hormone receptor autoantibodies (TRAb), along with thyroid follicular epithelial hyperplasia and lymphocytic infiltration of the gland (1, 2). Here, TSHR is linked to Graves disease.